Barclays PLC lifted its stake in shares of Quipt Home Medical Corp. (NASDAQ:QIPT – Free Report) by 79.2% during the third quarter, Holdings Channel.com reports. The fund owned 87,425 shares of the company’s stock after purchasing an additional 38,635 shares during the period. Barclays PLC’s holdings in Quipt Home Medical were worth $256,000 at the end of the most recent reporting period.
Other hedge funds have also made changes to their positions in the company. ProShare Advisors LLC acquired a new position in shares of Quipt Home Medical during the second quarter valued at approximately $35,000. SG Americas Securities LLC acquired a new position in shares of Quipt Home Medical during the third quarter valued at approximately $44,000. Atom Investors LP acquired a new position in shares of Quipt Home Medical during the third quarter valued at approximately $51,000. XTX Topco Ltd acquired a new position in shares of Quipt Home Medical during the third quarter valued at approximately $54,000. Finally, Jane Street Group LLC increased its stake in shares of Quipt Home Medical by 28.5% during the third quarter. Jane Street Group LLC now owns 41,926 shares of the company’s stock valued at $122,000 after acquiring an additional 9,290 shares during the period. Institutional investors and hedge funds own 42.85% of the company’s stock.
Insider Buying and Selling
In related news, VP Patrick Dennis Gamble bought 17,000 shares of the firm’s stock in a transaction on Thursday, December 26th. The stock was bought at an average price of $2.45 per share, with a total value of $41,650.00. Following the purchase, the vice president now directly owns 40,057 shares of the company’s stock, valued at approximately $98,139.65. This represents a 73.73 % increase in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Company insiders own 4.20% of the company’s stock.
Quipt Home Medical Trading Up 5.2 %
Quipt Home Medical (NASDAQ:QIPT – Get Free Report) last posted its quarterly earnings data on Monday, December 16th. The company reported ($0.07) EPS for the quarter, missing analysts’ consensus estimates of $0.01 by ($0.08). Quipt Home Medical had a negative return on equity of 4.51% and a negative net margin of 1.95%. On average, research analysts anticipate that Quipt Home Medical Corp. will post -0.1 EPS for the current fiscal year.
Quipt Home Medical Profile
Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment.
Featured Stories
- Five stocks we like better than Quipt Home Medical
- 3 Warren Buffett Stocks to Buy Now
- Cold Front, Hot Stocks: Diesel Prices Propel Energy Leaders
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Sustainable and Successful: 3 Climate ETFs Beating the Market
- How to Use Stock Screeners to Find Stocks
- Quantum Opportunity: Skywater Technology’s Long-Term Potential
Want to see what other hedge funds are holding QIPT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Quipt Home Medical Corp. (NASDAQ:QIPT – Free Report).
Receive News & Ratings for Quipt Home Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quipt Home Medical and related companies with MarketBeat.com's FREE daily email newsletter.